newdrugapprovals.org
NDA PA32540, Pozen Submits NDA for Aspirin Alternatives
PA32540 PA-325/40 (EC-ASA 325 mg + IR omeprazole 40 mg) enteric-coated aspirin (EC-ASA) 325 mg MAR 27,2013 Pozen Inc. announced the submission of a new drug application to the U.S. Food and Drug Ad…